Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
21-06873S
Grantová Agentura České Republiky
NU20J-08-00018
Agentura Pro Zdravotnický Výzkum České Republiky
PubMed
34706732
PubMed Central
PMC8549397
DOI
10.1186/s12943-021-01423-6
PII: 10.1186/s12943-021-01423-6
Knihovny.cz E-zdroje
- Klíčová slova
- Amphisomes, Autophagy, Autophagy inhibitors, Cancer, Endosomes, Exosomes, Extracellular vesicles, Multivesicular bodies, Non-conventional secretory pathways,
- MeSH
- autofagie účinky léků MeSH
- autofagozomy metabolismus MeSH
- cílená molekulární terapie * MeSH
- endocytóza účinky léků MeSH
- endozomy metabolismus MeSH
- exozómy metabolismus MeSH
- lidé MeSH
- nádory farmakoterapie etiologie metabolismus MeSH
- progrese nemoci MeSH
- proteolýza MeSH
- protinádorové látky farmakologie terapeutické užití MeSH
- sekreční dráha účinky léků MeSH
- signální transdukce účinky léků MeSH
- výsledek terapie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- protinádorové látky MeSH
Autophagy is best known for its role in organelle and protein turnover, cell quality control, and metabolism. The autophagic machinery has, however, also adapted to enable protein trafficking and unconventional secretory pathways so that organelles (such as autophagosomes and multivesicular bodies) delivering cargo to lysosomes for degradation can change their mission from fusion with lysosomes to fusion with the plasma membrane, followed by secretion of the cargo from the cell. Some factors with key signalling functions do not enter the conventional secretory pathway but can be secreted in an autophagy-mediated manner.Positive clinical results of some autophagy inhibitors are encouraging. Nevertheless, it is becoming clear that autophagy inhibition, even within the same cancer type, can affect cancer progression differently. Even next-generation inhibitors of autophagy can have significant non-specific effects, such as impacts on endosome-related secretory pathways and secretion of extracellular vesicles (EVs). Many studies suggest that cancer cells release higher amounts of EVs compared to non-malignant cells, which makes the effect of autophagy inhibitors on EVs secretion highly important and attractive for anticancer therapy. In this review article, we discuss how different inhibitors of autophagy may influence the secretion of EVs and summarize the non-specific effects of autophagy inhibitors with a focus on endosome-related secretory pathways. Modulation of autophagy significantly impacts not only the quantity of EVs but also their content, which can have a deep impact on the resulting pro-tumourigenic or anticancer effect of autophagy inhibitors used in the antineoplastic treatment of solid cancers.
Zobrazit více v PubMed
Mizushima N. Physiological functions of autophagy. Curr Top Microbiol Immunol. 2009;335:71–84. PubMed
Clarke AJ, Simon AK. Autophagy in the renewal, differentiation and homeostasis of immune cells. Nat Rev Immunol. 2019;19(3):170–183. doi: 10.1038/s41577-018-0095-2. PubMed DOI
Deretic V, Jiang S, Dupont N. Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation. Trends Cell Biol. 2012;22(8):397–406. doi: 10.1016/j.tcb.2012.04.008. PubMed DOI PMC
Salimi L, et al. Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells. Cell Biosci. 2020;10(1):64. doi: 10.1186/s13578-020-00426-y. PubMed DOI PMC
Kaushik S, Cuervo AM. The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol. 2018;19(6):365–381. doi: 10.1038/s41580-018-0001-6. PubMed DOI PMC
Jovic M, et al. The early endosome: a busy sorting station for proteins at the crossroads. Histol Histopathol. 2010;25(1):99–112. PubMed PMC
Barysch SV, et al. Sorting in early endosomes reveals connections to docking- and fusion-associated factors. Proc Natl Acad Sci. 2009;106(24):9697–9702. doi: 10.1073/pnas.0901444106. PubMed DOI PMC
Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75(2):193–208. doi: 10.1007/s00018-017-2595-9. PubMed DOI PMC
Murrow L, Malhotra R, Debnath J. ATG12–ATG3 interacts with Alix to promote basal autophagic flux and late endosome function. Nat Cell Biol. 2015;17(3):300–310. doi: 10.1038/ncb3112. PubMed DOI PMC
Fader CM, et al. Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in K562 cells. Traffic. 2008;9(2):230–250. doi: 10.1111/j.1600-0854.2007.00677.x. PubMed DOI
Abels ER, Breakefield XO. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol. 2016;36(3):301–312. doi: 10.1007/s10571-016-0366-z. PubMed DOI PMC
Ao X, Zou L, Wu Y. Regulation of autophagy by the Rab GTPase network. Cell Death Differ. 2014;21(3):348–358. doi: 10.1038/cdd.2013.187. PubMed DOI PMC
Fengsrud M, et al. Ultrastructural characterization of the delimiting membranes of isolated autophagosomes and amphisomes by freeze-fracture electron microscopy. Eur J Cell Biol. 2000;79(12):871–882. doi: 10.1078/0171-9335-00125. PubMed DOI
Lucocq J, Walker D. Evidence for fusion between multilamellar endosomes and autophagosomes in HeLa cells. Eur J Cell Biol. 1997;72(4):307–313. PubMed
Klionsky DJ, Eskelinen E-L, Deretic V. Autophagosomes, phagosomes, autolysosomes, phagolysosomes, autophagolysosomes... wait, I'm confused. Autophagy. 2014;10(4):549–551. doi: 10.4161/auto.28448. PubMed DOI PMC
Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1) Autophagy. 2021;17(1):1–382. doi: 10.1080/15548627.2020.1797280. PubMed DOI PMC
Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960–976. doi: 10.1016/j.cell.2017.02.004. PubMed DOI PMC
Jewell JL, et al. GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor. Elife. 2019;8. PubMed PMC
Gwinn DM, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214–226. doi: 10.1016/j.molcel.2008.03.003. PubMed DOI PMC
Prentzell MT, et al. G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling. Cell. 2021. PubMed PMC
González A, Hall MN. Nutrient sensing and TOR signaling in yeast and mammals. EMBO J. 2017;36(4):397–408. doi: 10.15252/embj.201696010. PubMed DOI PMC
Sancak Y, et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell. 2010;141(2):290–303. doi: 10.1016/j.cell.2010.02.024. PubMed DOI PMC
Zoncu R, et al. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H+-ATPase. Science. 2011;334:678–683. doi: 10.1126/science.1207056. PubMed DOI PMC
Mutvei AP, et al. Rap1-GTPases control mTORC1 activity by coordinating lysosome organization with amino acid availability. Nat Commun. 2020;11(1):1416. doi: 10.1038/s41467-020-15156-5. PubMed DOI PMC
Settembre C, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429–1433. doi: 10.1126/science.1204592. PubMed DOI PMC
Kundu ST, et al. TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins. Nat Commun. 2018;9(1):2731. doi: 10.1038/s41467-018-05013-x. PubMed DOI PMC
Karanasios E, et al. Autophagy initiation by ULK complex assembly on ER tubulovesicular regions marked by ATG9 vesicles. Nat Commun. 2016;7:12420. doi: 10.1038/ncomms12420. PubMed DOI PMC
Karanasios E, et al. Dynamic association of the ULK1 complex with omegasomes during autophagy induction. J Cell Sci. 2013;126(22):5224–5238. PubMed
Shima T, Kirisako H, Nakatogawa H. COPII vesicles contribute to autophagosomal membranes. J Cell Biol. 2019;218(5):1503–1510. doi: 10.1083/jcb.201809032. PubMed DOI PMC
Imai K, et al. Atg9A trafficking through the recycling endosomes is required for autophagosome formation. J Cell Sci. 2016;129(20):3781–3791. PubMed
Puri C, et al. ATG16L1 meets ATG9 in recycling endosomes: additional roles for the plasma membrane and endocytosis in autophagosome biogenesis. Autophagy. 2014;10(1):182–184. doi: 10.4161/auto.27174. PubMed DOI PMC
Lamb CA, Yoshimori T, Tooze SA. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol. 2013;14(12):759–774. doi: 10.1038/nrm3696. PubMed DOI
Boukhalfa A, et al. PI3KC2α-dependent and VPS34-independent generation of PI3P controls primary cilium-mediated autophagy in response to shear stress. Nat Commun. 2020;11(1):294. doi: 10.1038/s41467-019-14086-1. PubMed DOI PMC
Chowdhury S, et al. Insights into autophagosome biogenesis from structural and biochemical analyses of the ATG2A-WIPI4 complex. Proc Natl Acad Sci. 2018;115(42):E9792. doi: 10.1073/pnas.1811874115. PubMed DOI PMC
Maeda S, Otomo C, Otomo T. The autophagic membrane tether ATG2A transfers lipids between membranes. Elife. 2019;8. PubMed PMC
Dancourt J, Melia TJ. Lipidation of the autophagy proteins LC3 and GABARAP is a membrane-curvature dependent process. Autophagy. 2014;10(8):1470–1471. doi: 10.4161/auto.29468. PubMed DOI PMC
Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 2004;36(12):2503–2518. doi: 10.1016/j.biocel.2004.05.009. PubMed DOI PMC
Kharaziha P, Panaretakis T. Dynamics of Atg5-Atg12-Atg16L1 Aggregation and Deaggregation. Methods Enzymol. 2017;587:247–255. doi: 10.1016/bs.mie.2016.09.059. PubMed DOI
Agrotis A, et al. Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells. Autophagy. 2019;15(6):976–997. doi: 10.1080/15548627.2019.1569925. PubMed DOI PMC
Li M, et al. Kinetics comparisons of mammalian Atg4 homologues indicate selective preferences toward diverse Atg8 substrates. J Biol Chem. 2011;286(9):7327–7338. doi: 10.1074/jbc.M110.199059. PubMed DOI PMC
Takahashi Y, et al. An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closure. Nat Commun. 2018;9(1):2855. doi: 10.1038/s41467-018-05254-w. PubMed DOI PMC
Weidberg H, et al. LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J. 2010;29(11):1792–1802. doi: 10.1038/emboj.2010.74. PubMed DOI PMC
Grunwald DS, et al. GABARAPs and LC3s have opposite roles in regulating ULK1 for autophagy induction. Autophagy. 2020;16(4):600–614. doi: 10.1080/15548627.2019.1632620. PubMed DOI PMC
Yamamoto M, Suzuki SO, Himeno M. The effects of dynein inhibition on the autophagic pathway in glioma cells. Neuropathology. 2010;30(1):1–6. doi: 10.1111/j.1440-1789.2009.01034.x. PubMed DOI
Tong J, Yan X, Yu L. The late stage of autophagy: cellular events and molecular regulation. Protein Cell. 2010;1(10):907–915. doi: 10.1007/s13238-010-0121-z. PubMed DOI PMC
Kumar S, et al. Phosphorylation of Syntaxin 17 by TBK1 controls autophagy initiation. Dev Cell. 2019;49(1):130–144. doi: 10.1016/j.devcel.2019.01.027. PubMed DOI PMC
Wang C, et al. Phosphorylation of ULK1 affects autophagosome fusion and links chaperone-mediated autophagy to macroautophagy. Nat Commun. 2018;9(1):3492. doi: 10.1038/s41467-018-05449-1. PubMed DOI PMC
Viret C, Faure M. Regulation of syntaxin 17 during autophagosome maturation. Trends Cell Biol. 2019;29(1):1–3. doi: 10.1016/j.tcb.2018.10.003. PubMed DOI
Choi YJ, et al. Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion. PLoS One. 2012;7(8):e43418. doi: 10.1371/journal.pone.0043418. PubMed DOI PMC
Itakura E, et al. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell. 2008;19(12):5360–5372. doi: 10.1091/mbc.e08-01-0080. PubMed DOI PMC
Liang C, et al. Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat Cell Biol. 2008;10(7):776–787. doi: 10.1038/ncb1740. PubMed DOI PMC
Takahashi Y, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol. 2007;9(10):1142–1151. doi: 10.1038/ncb1634. PubMed DOI PMC
Keulers TG, Schaaf MBE, Rouschop KMA. Autophagy-dependent secretion: contribution to tumor progression. Front Oncol. 2016;6(251). PubMed PMC
Liang XH, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402(6762):672–676. doi: 10.1038/45257. PubMed DOI
Yue Z, et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100(25):15077–15082. doi: 10.1073/pnas.2436255100. PubMed DOI PMC
Kang MR, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol. 2009;217(5):702–706. doi: 10.1002/path.2509. PubMed DOI
Wible DJ, et al. ATG5 cancer mutations and alternative mRNA splicing reveal a conjugation switch that regulates ATG12-ATG5-ATG16L1 complex assembly and autophagy. Cell Discov. 2019;5:42. doi: 10.1038/s41421-019-0110-1. PubMed DOI PMC
Ueno T, et al. Loss of Pten, a tumor suppressor, causes the strong inhibition of autophagy without affecting LC3 lipidation. Autophagy. 2008;4(5):692–700. doi: 10.4161/auto.6085. PubMed DOI
Hou W, et al. Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma. Oncol Lett. 2014;8(3):1249–1254. doi: 10.3892/ol.2014.2253. PubMed DOI PMC
Chen X, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39(7):1557–1571. doi: 10.1038/s41388-019-1085-y. PubMed DOI PMC
Johnson CE, et al. Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death. Oncogene. 2018;37(45):5913–5925. doi: 10.1038/s41388-018-0381-2. PubMed DOI
Chang WH, Lai AG. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types. BMC Cancer. 2020;20(1):773. doi: 10.1186/s12885-020-07286-2. PubMed DOI PMC
Zijian Z, et al. Research square. 2021.
Claude-Taupin A, et al. ATG9A is overexpressed in triple negative breast cancer and its in vitro extinction leads to the inhibition of pro-cancer phenotypes. Cells. 2018;7(12):248. doi: 10.3390/cells7120248. PubMed DOI PMC
Caron A, et al. DEPTOR at the nexus of cancer, metabolism, and immunity. Physiol Rev. 2018;98(3):1765–1803. doi: 10.1152/physrev.00064.2017. PubMed DOI PMC
Hu B, et al. Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway. Onco Targets Ther. 2017;10:4379–4391. doi: 10.2147/OTT.S143518. PubMed DOI PMC
Chen R, Yang Q, Lee J-D. BMK1 kinase suppresses epithelial–mesenchymal transition through the Akt/GSK3β signaling pathway. Cancer Res. 2012;72(6):1579–1587. doi: 10.1158/0008-5472.CAN-11-2055. PubMed DOI PMC
Parvani JG, et al. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression. Neoplasia. 2015;17(3):317–328. doi: 10.1016/j.neo.2015.02.003. PubMed DOI PMC
Pei L, et al. Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma. Mol Med Rep. 2011;4(5):817–823. PubMed
Okamoto T, et al. FIP200 suppresses immune checkpoint therapy responses in breast cancers by limiting AZI2/TBK1/IRF signaling independent of its canonical autophagy function. Cancer Res. 2020;80(17):3580–3592. doi: 10.1158/0008-5472.CAN-20-0519. PubMed DOI PMC
Wang D, et al. Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity. PLoS One. 2011;6(5):e19629. doi: 10.1371/journal.pone.0019629. PubMed DOI PMC
Yu X-N, et al. Enhanced mLST8 expression correlates with tumor progression in hepatocellular carcinoma. Ann Surg Oncol. 2020;27(5):1546–1557. doi: 10.1245/s10434-020-08263-6. PubMed DOI
Chen S, et al. Inhibition of PI3K/Akt/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis. Oncotarget. 2017;8(31):50476–50488. doi: 10.18632/oncotarget.9919. PubMed DOI PMC
Mossmann D, Park S, Hall MN. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer. 2018;18(12):744–757. doi: 10.1038/s41568-018-0074-8. PubMed DOI
Zou Z, et al. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci. 2020;10(1):31. doi: 10.1186/s13578-020-00396-1. PubMed DOI PMC
Qi Z, et al. PRAS40 hyperexpression promotes hepatocarcinogenesis. EBioMedicine. 2020;51. PubMed PMC
Zhu G, et al. PRAS40 promotes NF-κB transcriptional activity through association with p65. Oncogenesis. 2017;6(9):e381. doi: 10.1038/oncsis.2017.80. PubMed DOI PMC
Nussinov R, et al. The mystery of Rap1 suppression of oncogenic ras. Trends Cancer. 2020;6(5):369–379. doi: 10.1016/j.trecan.2020.02.002. PubMed DOI PMC
Zhang Y-L, et al. Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol Med. 2017;14(1):90–99. doi: 10.20892/j.issn.2095-3941.2016.0086. PubMed DOI PMC
Earwaker P, et al. RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition. PLoS One. 2018;13(2):e0191890. doi: 10.1371/journal.pone.0191890. PubMed DOI PMC
Wang T, et al. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1. Cancer Med. 2020;9(4):1529–1543. doi: 10.1002/cam4.2810. PubMed DOI PMC
Kondo S, et al. Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma. BMC Cancer. 2021;21(1):87. doi: 10.1186/s12885-021-07794-9. PubMed DOI PMC
Kauffman EC, et al. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol. 2014;11(8):465–475. doi: 10.1038/nrurol.2014.162. PubMed DOI PMC
Kim JH, et al. TFEB supports pancreatic cancer growth through the transcriptional regulation of glutaminase. Cancers. 2021;13(3):483. doi: 10.3390/cancers13030483. PubMed DOI PMC
Li Y, et al. TFEB is a master regulator of tumor-associated macrophages in breast cancer. J ImmunoTher Cancer. 2020;8(1):e000543. doi: 10.1136/jitc-2020-000543. PubMed DOI PMC
Medina DL, et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell. 2011;21(3):421–430. doi: 10.1016/j.devcel.2011.07.016. PubMed DOI PMC
Astanina E, Bussolino F, Doronzo G. Multifaceted activities of transcription factor EB in cancer onset and progression. Mol Oncol. 2021;15(2):327–346. doi: 10.1002/1878-0261.12867. PubMed DOI PMC
Astrinidis A, et al. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene. 2002;21(55):8470–8476. doi: 10.1038/sj.onc.1205962. PubMed DOI
Deng J, et al. ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer. Nat Can. 2021;2(5):503–514. doi: 10.1038/s43018-021-00208-6. PubMed DOI PMC
Kumar M, Papaleo E. A pan-cancer assessment of alterations of the kinase domain of ULK1, an upstream regulator of autophagy. Sci Rep. 2020;10(1):14874. doi: 10.1038/s41598-020-71527-4. PubMed DOI PMC
TAN L, TAN Y, LIU D. Functions of ULK1 in autophagy and non-autophagy pathways and its implications in human physiology and disease. Biocell. 2020;44(4):535–543. doi: 10.32604/biocell.2020.09171. DOI
Li Z, et al. ULK1-ATG13 and their mitotic phospho-regulation by CDK1 connect autophagy to cell cycle. PLoS Biol. 2020;18(6):e3000288. doi: 10.1371/journal.pbio.3000288. PubMed DOI PMC
De Luca M, Romano R, Bucci C. Role of the V1G1 subunit of V-ATPase in breast cancer cell migration. Sci Rep. 2021;11(1):4615. doi: 10.1038/s41598-021-84222-9. PubMed DOI PMC
Huang L, et al. ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells. Diagn Pathol. 2012;7:180. doi: 10.1186/1746-1596-7-180. PubMed DOI PMC
Lu Q, et al. The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer. Diagn Pathol. 2013;8:145. doi: 10.1186/1746-1596-8-145. PubMed DOI PMC
Noman MZ, et al. Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy. Sci Adv. 2020;6(18):eaax7881. doi: 10.1126/sciadv.aax7881. PubMed DOI PMC
Liu F, et al. PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cell activity induced by PI3K inhibitor. Cell Death Dis. 2020;11(6):427. doi: 10.1038/s41419-020-2631-9. PubMed DOI PMC
Jiang X, et al. VPS34 stimulation of p62 phosphorylation for cancer progression. Oncogene. 2017;36. PubMed PMC
Parekh VV, et al. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α<sup>+</sup> dendritic cells. Proc Natl Acad Sci. 2017;114(31):E6371–E6380. doi: 10.1073/pnas.1706504114. PubMed DOI PMC
Liang T-T, et al. Systemic expression analysis reveals prognostic significance of WIPI3 in hepatocellular carcinoma. Front Genet. 2020;11(847). PubMed PMC
Kean MJ, et al. VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion. J Cell Sci. 2009;122(Pt 22):4089–4098. doi: 10.1242/jcs.052761. PubMed DOI
Sneeggen M, Schink KO, Stenmark H. Tumor suppression by control of matrix metalloproteinase recycling. Mol Cell Oncol. 2019;6(6):e1646606. doi: 10.1080/23723556.2019.1646606. PubMed DOI PMC
Miao Y, et al. GABARAP is overexpressed in colorectal carcinoma and correlates with shortened patient survival. Hepatogastroenterology. 2010;57(98):257–261. PubMed
Liu Y, et al. GABARAP suppresses EMT and breast cancer progression via the AKT/mTOR signaling pathway. Aging. 2021;13(4):5858–5874. doi: 10.18632/aging.202510. PubMed DOI PMC
Othman EQ, et al. Immunohistochemical expression of MAP1LC3A and MAP1LC3B protein in breast carcinoma tissues. J Clin Lab Anal. 2009;23(4):249–258. doi: 10.1002/jcla.20309. PubMed DOI PMC
Kang HM, et al. Ubiquitination of MAP1LC3B by pVHL is associated with autophagy and cell death in renal cell carcinoma. Cell Death Dis. 2019;10(4):279. doi: 10.1038/s41419-019-1520-6. PubMed DOI PMC
Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19(1):12. doi: 10.1186/s12943-020-1138-4. PubMed DOI PMC
Sadler JBA, et al. A cancer-associated polymorphism in ESCRT-III disrupts the abscission checkpoint and promotes genome instability. Proc Natl Acad Sci U S A. 2018;115(38):E8900–E8908. doi: 10.1073/pnas.1805504115. PubMed DOI PMC
Song Y, Quach C, Liang C. UVRAG in autophagy, inflammation, and cancer. Autophagy. 2020;16(2):387–388. doi: 10.1080/15548627.2019.1709768. PubMed DOI PMC
Ahn CH, et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS. 2007;115(12):1344–1349. doi: 10.1111/j.1600-0463.2007.00858.x. PubMed DOI
Hao M, Yeo SK, Guan J-L. Autophagy inhibition perturbs ERBB2 trafficking and abolishes tumorigenesis in ERBB2-driven breast cancer. Autophagy. 2021;17(4):1059–1060. doi: 10.1080/15548627.2021.1907168. PubMed DOI PMC
Cararo-Lopes E, et al. Autophagy buffers Ras-induced genotoxic stress enabling malignant transformation in keratinocytes primed by human papillomavirus. Cell Death Dis. 2021;12(2):194. doi: 10.1038/s41419-021-03476-3. PubMed DOI PMC
Jiang G-M, et al. The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Mol Cancer. 2019;18(1):17. doi: 10.1186/s12943-019-0944-z. PubMed DOI PMC
Fung C, et al. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell. 2008;19(3):797–806. doi: 10.1091/mbc.e07-10-1092. PubMed DOI PMC
Nazio F, et al. Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications. Cell Death Differ. 2019;26(4):690–702. doi: 10.1038/s41418-019-0292-y. PubMed DOI PMC
Pérez-Hernández M, et al. Targeting autophagy for cancer treatment and tumor chemosensitization. Cancers. 2019;11(10):1599. doi: 10.3390/cancers11101599. PubMed DOI PMC
Maes H, et al. Autophagy: shaping the tumor microenvironment and therapeutic response. Trends Mol Med. 2013;19(7):428–446. doi: 10.1016/j.molmed.2013.04.005. PubMed DOI
Sharifi MN, et al. Autophagy promotes focal adhesion disassembly and cell motility of metastatic tumor cells through the direct interaction of paxillin with LC3. Cell Rep. 2016;15(8):1660–1672. doi: 10.1016/j.celrep.2016.04.065. PubMed DOI PMC
Karsli-Uzunbas G, et al. Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov. 2014;4(8):914–927. doi: 10.1158/2159-8290.CD-14-0363. PubMed DOI PMC
Catalano M, et al. Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells. Mol Oncol. 2015;9(8):1612–1625. doi: 10.1016/j.molonc.2015.04.016. PubMed DOI PMC
La Belle Flynn A, et al. Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression. Nat Commun. 2019;10(1):3668. doi: 10.1038/s41467-019-11640-9. PubMed DOI PMC
Pietrocola F, et al. Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell. 2016;30(1):147–160. doi: 10.1016/j.ccell.2016.05.016. PubMed DOI PMC
Kimura T, et al. Cellular and molecular mechanism for secretory autophagy. Autophagy. 2017;13(6):1084–1085. doi: 10.1080/15548627.2017.1307486. PubMed DOI PMC
Lock R, et al. Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov. 2014;4(4):466–479. doi: 10.1158/2159-8290.CD-13-0841. PubMed DOI PMC
Hong Z, et al. PtdIns3P controls mTORC1 signaling through lysosomal positioning. J Cell Biol. 2017;216(12):4217–4233. doi: 10.1083/jcb.201611073. PubMed DOI PMC
Marat AL, Haucke V. Phosphatidylinositol 3-phosphates—at the interface between cell signalling and membrane traffic. EMBO J. 2016;35(6):561–579. doi: 10.15252/embj.201593564. PubMed DOI PMC
Poteryaev D, et al. Identification of the Switch in early-to-late endosome transition. Cell. 2010;141(3):497–508. doi: 10.1016/j.cell.2010.03.011. PubMed DOI
Bache KG, et al. Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol. 2003;162(3):435–442. doi: 10.1083/jcb.200302131. PubMed DOI PMC
Futter CE, et al. Human VPS34 is required for internal vesicle formation within multivesicular endosomes. J Cell Biol. 2001;155(7):1251–1264. doi: 10.1083/jcb.200108152. PubMed DOI PMC
Xu Y, et al. SNX3 regulates endosomal function through its PX-domain-mediated interaction with PtdIns(3)P. Nat Cell Biol. 2001;3(7):658–666. doi: 10.1038/35083051. PubMed DOI
Knævelsrud H, et al. Membrane remodeling by the PX-BAR protein SNX18 promotes autophagosome formation. J Cell Biol. 2013;202(2):331–349. doi: 10.1083/jcb.201205129. PubMed DOI PMC
Bechtel W, et al. Vps34 deficiency reveals the importance of endocytosis for podocyte homeostasis. J Am Soc Nephrol. 2013;24(5):727–743. doi: 10.1681/ASN.2012070700. PubMed DOI PMC
Siddhanta U, et al. Distinct roles for the p110alpha and hVPS34 phosphatidylinositol 3'-kinases in vesicular trafficking, regulation of the actin cytoskeleton, and mitogenesis. J Cell Biol. 1998;143(6):1647–1659. doi: 10.1083/jcb.143.6.1647. PubMed DOI PMC
Nascimbeni AC, Codogno P, Morel E. Phosphatidylinositol-3-phosphate in the regulation of autophagy membrane dynamics. FEBS J. 2017;284(9):1267–1278. doi: 10.1111/febs.13987. PubMed DOI
Ketel K, et al. A phosphoinositide conversion mechanism for exit from endosomes. Nature. 2016;529(7586):408–412. doi: 10.1038/nature16516. PubMed DOI
Miranda AM, Di Paolo G. Endolysosomal dysfunction and exosome secretion: implications for neurodegenerative disorders. Cell Stress. 2018;2(5):115–118. doi: 10.15698/cst2018.05.136. PubMed DOI PMC
Law F, et al. The VPS34 PI3K negatively regulates RAB-5 during endosome maturation. J Cell Sci. 2017;130(12):2007–2017. PubMed PMC
Jaber N, et al. Vps34 regulates Rab7 and late endocytic trafficking through recruitment of the GTPase-activating protein Armus. J Cell Sci. 2016;129(23):4424–4435. PubMed PMC
Baietti MF, et al. Syndecan–syntenin–ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14(7):677–685. doi: 10.1038/ncb2502. PubMed DOI
Sapmaz A, et al. USP32 regulates late endosomal transport and recycling through deubiquitylation of Rab7. Nat Commun. 2019;10(1):1454. doi: 10.1038/s41467-019-09437-x. PubMed DOI PMC
Odorizzi G, Babst M, Emr SD. Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell. 1998;95(6):847–858. doi: 10.1016/S0092-8674(00)81707-9. PubMed DOI
Falguières T, et al. In vitro budding of intralumenal vesicles into late endosomes is regulated by Alix and Tsg101. Mol Biol Cell. 2008;19(11):4942–4955. doi: 10.1091/mbc.e08-03-0239. PubMed DOI PMC
Hikita T, et al. Src in endosomal membranes promotes exosome secretion and tumor progression. Sci Rep. 2019;9(1):3265. doi: 10.1038/s41598-019-39882-z. PubMed DOI PMC
Ghossoub R, et al. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat Commun. 2014;5:3477. doi: 10.1038/ncomms4477. PubMed DOI
Ostrowski M, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19–30. doi: 10.1038/ncb2000. PubMed DOI
Hoshino D, et al. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep. 2013;5(5):1159–1168. doi: 10.1016/j.celrep.2013.10.050. PubMed DOI PMC
Yang L, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer. 2019;18(1):78. doi: 10.1186/s12943-019-0990-6. PubMed DOI PMC
Yang L, et al. The long noncoding RNA HOTAIR activates autophagy by upregulating ATG3 and ATG7 in hepatocellular carcinoma. Mol BioSyst. 2016;12(8):2605–2612. doi: 10.1039/C6MB00114A. PubMed DOI
Peng X, et al. LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation. J Exp Clin Cancer Res. 2021;40(1):183. doi: 10.1186/s13046-021-01990-y. PubMed DOI PMC
Agbana YL, et al. LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis. BMC Cancer. 2020;20(1):682. doi: 10.1186/s12885-020-07188-3. PubMed DOI PMC
Dong X, et al. Long noncoding RNA LINC00511 regulates the proliferation, apoptosis, invasion and autophagy of trophoblast cells to mediate pre-eclampsia progression through modulating the miR-31-5p/homeobox protein A7 axis. J Obstet Gynaecol Res. 2020;46(8):1298–1309. doi: 10.1111/jog.14344. PubMed DOI
Sinha S, et al. Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol. 2016;214(2):197–213. doi: 10.1083/jcb.201601025. PubMed DOI PMC
Villarroya-Beltri C, et al. ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat Commun. 2016;7:13588. doi: 10.1038/ncomms13588. PubMed DOI PMC
Majumder P, Chakrabarti O. Mahogunin regulates fusion between amphisomes/MVBs and lysosomes via ubiquitination of TSG101. Cell Death Dis. 2015;6(11):e1970. doi: 10.1038/cddis.2015.257. PubMed DOI PMC
Buschow SI, et al. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic. 2009;10(10):1528–1542. doi: 10.1111/j.1600-0854.2009.00963.x. PubMed DOI
Möbius W, et al. Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O. J Histochem Cytochem. 2002;50(1):43–55. doi: 10.1177/002215540205000105. PubMed DOI
Möbius W, et al. Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic. 2003;4:222–231. doi: 10.1034/j.1600-0854.2003.00072.x. PubMed DOI
Jordens I, et al. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr Biol. 2001;11(21):1680–1685. doi: 10.1016/S0960-9822(01)00531-0. PubMed DOI
Jongsma ML, et al. SKIP-HOPS recruits TBC1D15 for a Rab7-to-Arl8b identity switch to control late endosome transport. EMBO J. 2020;39(6):e102301. doi: 10.15252/embj.2019102301. PubMed DOI PMC
Guo H, et al. Atg5 disassociates the V1V0-ATPase to promote exosome production and tumor metastasis independent of canonical macroautophagy. Dev Cell. 2017;43(6):716–730.e7. doi: 10.1016/j.devcel.2017.11.018. PubMed DOI
Savina A, et al. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic. 2005;6(2):131–143. doi: 10.1111/j.1600-0854.2004.00257.x. PubMed DOI
Wang K, et al. Mechanical stress-dependent autophagy component release via extracellular nanovesicles in tumor cells. ACS Nano. 2019;13(4):4589–4602. doi: 10.1021/acsnano.9b00587. PubMed DOI
Fader CM, et al. TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. Biochim Biophys Acta. 2009;1793(12):1901–1916. doi: 10.1016/j.bbamcr.2009.09.011. PubMed DOI
Lefebvre C, Legouis R, Culetto E. ESCRT and autophagies: Endosomal functions and beyond. Semin Cell Dev Biol. 2018;74:21–28. doi: 10.1016/j.semcdb.2017.08.014. PubMed DOI
Chen Y-D, et al. Exophagy of annexin A2 via RAB11, RAB8A and RAB27A in IFN-γ-stimulated lung epithelial cells. Sci Rep. 2017;7(1):5676. doi: 10.1038/s41598-017-06076-4. PubMed DOI PMC
Bader CA, et al. Atg9 is required for intraluminal vesicles in amphisomes and autolysosomes. Biol Open. 2015;4(11):1345–1355. doi: 10.1242/bio.013979. PubMed DOI PMC
Moreau K, et al. Autophagosome precursor maturation requires homotypic fusion. Cell. 2011;146(2):303–317. doi: 10.1016/j.cell.2011.06.023. PubMed DOI PMC
Fader CM, Aguilera MO, Colombo MI. ATP is released from autophagic vesicles to the extracellular space in a VAMP7-dependent manner. Autophagy. 2012;8(12):1741–1756. doi: 10.4161/auto.21858. PubMed DOI PMC
Jeppesen DK, et al. Reassessment of exosome composition. Cell. 2019;177(2):428–445.e18. doi: 10.1016/j.cell.2019.02.029. PubMed DOI PMC
Baixauli F, López-Otín C, Mittelbrunn M. Exosomes and autophagy: coordinated mechanisms for the maintenance of cellular fitness. Front Immunol. 2014;5:403. doi: 10.3389/fimmu.2014.00403. PubMed DOI PMC
Omi J, et al. The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection. Nat Commun. 2020;11(1):162. doi: 10.1038/s41467-019-13974-w. PubMed DOI PMC
Kraya AA, et al. Identification of secreted proteins that reflect autophagy dynamics within tumor cells. Autophagy. 2015;11(1):60–74. doi: 10.4161/15548627.2014.984273. PubMed DOI PMC
Dupont N, et al. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J. 2011;30(23):4701–4711. doi: 10.1038/emboj.2011.398. PubMed DOI PMC
Zhang M, et al. Translocation of interleukin-1β into a vesicle intermediate in autophagy-mediated secretion. Elife. 2015;4. PubMed PMC
New J, Thomas SM. Autophagy-dependent secretion: mechanism, factors secreted, and disease implications. Autophagy. 2019;15(10):1682–1693. doi: 10.1080/15548627.2019.1596479. PubMed DOI PMC
Kimura T, et al. Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. EMBO J. 2017;36(1):42–60. doi: 10.15252/embj.201695081. PubMed DOI PMC
Qiang L, et al. Autophagy gene ATG7 regulates ultraviolet radiation-induced inflammation and skin tumorigenesis. Autophagy. 2017;13(12):2086–2103. doi: 10.1080/15548627.2017.1380757. PubMed DOI PMC
Peng X, et al. IKKβ activation promotes amphisome formation and extracellular vesicle secretion in tumor cells. Biochim Biophys Acta Mol Cell Res. 1868;2021(1):118857. doi: 10.1016/j.bbamcr.2020.118857. PubMed DOI
Maycotte P, et al. Autophagy supports breast cancer stem cell maintenance by regulating IL6 secretion. Mol Cancer Res. 2015;13(4):651–658. doi: 10.1158/1541-7786.MCR-14-0487. PubMed DOI PMC
Huang S-C, et al. Discovery and optimization of pyrazolopyrimidine sulfamates as ATG7 inhibitors. Bioorg Med Chem. 2020;28(19):115681. doi: 10.1016/j.bmc.2020.115681. PubMed DOI
King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012;12:421. doi: 10.1186/1471-2407-12-421. PubMed DOI PMC
Daskalaki I, Gkikas I, Tavernarakis N. Hypoxia and selective autophagy in cancer development and therapy. Front Cell Dev Biol. 2018;6(104). PubMed PMC
Kanemoto S, et al. Multivesicular body formation enhancement and exosome release during endoplasmic reticulum stress. Biochem Biophys Res Commun. 2016;480(2):166–172. doi: 10.1016/j.bbrc.2016.10.019. PubMed DOI
Bhattacharya S, et al. GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways. PLoS One. 2014;9(12):e114409. doi: 10.1371/journal.pone.0114409. PubMed DOI PMC
Muders MH, et al. Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. Clin Cancer Res. 2009;15(12):4095–4103. doi: 10.1158/1078-0432.CCR-08-2837. PubMed DOI PMC
Dutta S, et al. Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PLoS One. 2014;9(5):e97580. doi: 10.1371/journal.pone.0097580. PubMed DOI PMC
Wu Q, et al. Exosomes from the tumour-adipocyte interplay stimulate beige/brown differentiation and reprogram metabolism in stromal adipocytes to promote tumour progression. J Exp Clin Cancer Res. 2019;38(1):223. doi: 10.1186/s13046-019-1210-3. PubMed DOI PMC
Xu J, et al. Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction. Cell Death Dis. 2021;12(4):373. doi: 10.1038/s41419-021-03664-1. PubMed DOI PMC
Yang Y, et al. Acquisition of new tumor cell properties by MSC-derived exosomes. Int J Oncol. 2015;47(1):244–252. doi: 10.3892/ijo.2015.3001. PubMed DOI
Kucharewicz K, et al. Simultaneous induction and blockade of autophagy by a single agent. Cell Death Dis. 2018;9(3):353. doi: 10.1038/s41419-018-0383-6. PubMed DOI PMC
Chen Y, et al. Increased interleukin-6 levels in the astrocyte-derived exosomes of sporadic amyotrophic lateral sclerosis patients. Front Neurosci. 2019;13(574). PubMed PMC
Im K, et al. The comparison of exosome and exosomal cytokines between young and old individuals with or without gastric cancer. Int J Gerontol. 2018;12(3):233–238. doi: 10.1016/j.ijge.2018.03.013. DOI
Qin B, et al. IL-6 Inhibits Starvation-induced Autophagy via the STAT3/Bcl-2 Signaling Pathway. Sci Rep. 2015;5:15701. doi: 10.1038/srep15701. PubMed DOI PMC
Linnemann A, et al. Interleukin 6 protects pancreatic β cells from apoptosis by stimulation of autophagy. FASEB J. 2017;31. PubMed PMC
Frühbeis C, et al. Physical exercise induces rapid release of small extracellular vesicles into the circulation. J Extracell Vesicles. 2015;4(1):28239. doi: 10.3402/jev.v4.28239. PubMed DOI PMC
Follo C, et al. Inhibition of autophagy initiation potentiates chemosensitivity in mesothelioma. Mol Carcinog. 2018;57(3):319–332. doi: 10.1002/mc.22757. PubMed DOI
Zachari M, Ganley IG. The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017;61(6):585–596. doi: 10.1042/EBC20170021. PubMed DOI PMC
Petherick KJ, et al. Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem. 2015;290(18):11376–11383. doi: 10.1074/jbc.C114.627778. PubMed DOI PMC
Young ARJ, et al. Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes. J Cell Sci. 2006;119(18):3888–3900. doi: 10.1242/jcs.03172. PubMed DOI
Urano Y, et al. 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway. Autophagy. 2018;14(11):1943–1958. doi: 10.1080/15548627.2018.1493043. PubMed DOI PMC
Scotto Rosato A, et al. TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKβ/VPS34 pathway. Nat Commun. 2019;10(1):5630. doi: 10.1038/s41467-019-13572-w. PubMed DOI PMC
Zhou X, et al. Unc-51-like kinase 1/2-mediated endocytic processes regulate filopodia extension and branching of sensory axons. Proc Natl Acad Sci. 2007;104(14):5842–5847. doi: 10.1073/pnas.0701402104. PubMed DOI PMC
Chen Y, et al. Dual targeting of NUAK1 and ULK1 using the multitargeted inhibitor MRT68921 exerts potent antitumor activities. Cell Death Dis. 2020;11(8):712. doi: 10.1038/s41419-020-02885-0. PubMed DOI PMC
Palamiuc L, Ravi A, Emerling BM. Phosphoinositides in autophagy: current roles and future insights. FEBS J. 2020;287(2):222–238. doi: 10.1111/febs.15127. PubMed DOI PMC
Zhou C, et al. The heme oxygenase-1 inhibitor ZnPPIX induces non-canonical, Beclin 1-independent, autophagy through p38 MAPK pathway. Acta Biochim Biophys Sin. 2012;44:815–822. doi: 10.1093/abbs/gms064. PubMed DOI
Wu YT, et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010;285(14):10850–10861. doi: 10.1074/jbc.M109.080796. PubMed DOI PMC
Xing C, et al. Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901. Acta Biochim Biophys Sin Shanghai. 2008;40(3):194–201. doi: 10.1111/j.1745-7270.2008.00393.x. PubMed DOI
Seglen PO, Gordon PB. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A. 1982;79(6):1889–1892. doi: 10.1073/pnas.79.6.1889. PubMed DOI PMC
Lelouard H, et al. Regulation of translation is required for dendritic cell function and survival during activation. J Cell Biol. 2007;179(7):1427–1439. doi: 10.1083/jcb.200707166. PubMed DOI PMC
Chicote J, et al. Cell death triggered by the autophagy inhibitory drug 3-methyladenine in growing conditions proceeds with DNA damage. Front Pharmacol. 2020;11:580343. doi: 10.3389/fphar.2020.580343. PubMed DOI PMC
Caro LH, et al. 3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism. Eur J Biochem. 1988;175(2):325–329. doi: 10.1111/j.1432-1033.1988.tb14200.x. PubMed DOI
Korolchuk VI, et al. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell. 2009;33(4):517–527. doi: 10.1016/j.molcel.2009.01.021. PubMed DOI PMC
Zhang H-G, Grizzle WE. Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions. Am J Pathol. 2014;184(1):28–41. doi: 10.1016/j.ajpath.2013.09.027. PubMed DOI PMC
Zhang J, et al. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res Ther. 2016;7:136. doi: 10.1186/s13287-016-0391-3. PubMed DOI PMC
Clayton A, et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 2001;247(1-2):163–174. doi: 10.1016/S0022-1759(00)00321-5. PubMed DOI
Llorente A, de Marco MAC, Alonso MA. Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line. J Cell Sci. 2004;117(22):5343–5351. doi: 10.1242/jcs.01420. PubMed DOI
Abdulrahman BA, Abdelaziz DH, Schatzl HM. Autophagy regulates exosomal release of prions in neuronal cells. J Biol Chem. 2018;293(23):8956–8968. doi: 10.1074/jbc.RA117.000713. PubMed DOI PMC
Bright NA, et al. The relationship between lumenal and limiting membranes in swollen late endocytic compartments formed after wortmannin treatment or sucrose accumulation. Traffic. 2001;2(9):631–642. doi: 10.1034/j.1600-0854.2001.20906.x. PubMed DOI
Isosaki M. Inhibition of wortmannin activities by amino compounds. Biochem Biophys Res Commun. 2004;324(4):1406–1412. doi: 10.1016/j.bbrc.2004.09.200. PubMed DOI
Iula L, et al. Autophagy mediates interleukin-1β secretion in human neutrophils. Front Immunol. 2018;9:269. doi: 10.3389/fimmu.2018.00269. PubMed DOI PMC
Harris J, et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. 2011;286(11):9587–9597. doi: 10.1074/jbc.M110.202911. PubMed DOI PMC
Fukao T, et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol. 2002;3(9):875–881. doi: 10.1038/ni825. PubMed DOI
Miranda AM, et al. Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures. Nat Commun. 2018;9(1):291. doi: 10.1038/s41467-017-02533-w. PubMed DOI PMC
Liu J, et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell. 2011;147(1):223–234. doi: 10.1016/j.cell.2011.08.037. PubMed DOI PMC
Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006;66(9):4795–4801. doi: 10.1158/0008-5472.CAN-05-4579. PubMed DOI
Liu J, et al. Distinct dasatinib-induced mechanisms of apoptotic response and exosome release in imatinib-resistant human chronic myeloid leukemia cells. Int J Mol Sci. 2016;17(4):531. doi: 10.3390/ijms17040531. PubMed DOI PMC
Wang C, et al. Autophagic lipid metabolism sustains mTORC1 activity in TSC-deficient neural stem cells. Nat Metab. 2019;1(11):1127–1140. doi: 10.1038/s42255-019-0137-5. PubMed DOI PMC
McKnight NC, et al. Beclin 1 is required for neuron viability and regulates endosome pathways via the UVRAG-VPS34 complex. PLoS Genet. 2014;10(10):e1004626. doi: 10.1371/journal.pgen.1004626. PubMed DOI PMC
McKnight NC, Yue Z. Beclin 1, an essential component and master regulator of PI3K-III in health and disease. Curr Pathobiol Rep. 2013;1(4):231–238. doi: 10.1007/s40139-013-0028-5. PubMed DOI PMC
Gladue DP, et al. Foot-and-mouth disease virus nonstructural protein 2C interacts with Beclin1, modulating virus replication. J Virol. 2012;86(22):12080–12090. doi: 10.1128/JVI.01610-12. PubMed DOI PMC
Robke L, et al. Phenotypic identification of a novel autophagy inhibitor chemotype targeting lipid kinase VPS34. Angew Chem Int Ed. 2017;56(28):8153–8157. doi: 10.1002/anie.201703738. PubMed DOI
Marsh T, Debnath J. Ironing out VPS34 inhibition. Nat Cell Biol. 2014;17:1–3. doi: 10.1038/ncb3089. PubMed DOI
Ronan B, et al. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nat Chem Biol. 2014;10(12):1013–1019. doi: 10.1038/nchembio.1681. PubMed DOI
Wu Y, et al. Synthesis and screening of 3-MA derivatives for autophagy inhibitors. Autophagy. 2013;9(4):595–603. doi: 10.4161/auto.23641. PubMed DOI PMC
Vats S, Manjithaya R. A reversible autophagy inhibitor blocks autophagosome–lysosome fusion by preventing Stx17 loading onto autophagosomes. Mol Biol Cell. 2019;30(17):2283–2295. doi: 10.1091/mbc.E18-08-0482. PubMed DOI PMC
Keller MD, et al. Decoy exosomes provide protection against bacterial toxins. Nature. 2020;579(7798):260–264. doi: 10.1038/s41586-020-2066-6. PubMed DOI PMC
Cheng X-T, et al. Axonal autophagosomes recruit dynein for retrograde transport through fusion with late endosomes. J Cell Biol. 2015;209(3):377–386. doi: 10.1083/jcb.201412046. PubMed DOI PMC
Al-Bari A. Chloroquine analogues in drug discovery: New directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2015;70. PubMed PMC
Mauthe M, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435–1455. doi: 10.1080/15548627.2018.1474314. PubMed DOI PMC
Lu S, et al. Lysosomal adaptation: how cells respond to lysosomotropic compounds. PLoS One. 2017;12(3):e0173771. doi: 10.1371/journal.pone.0173771. PubMed DOI PMC
Gallagher LE, et al. Lysosomotropism depends on glucose: a chloroquine resistance mechanism. Cell Death Dis. 2017;8(8):e3014. doi: 10.1038/cddis.2017.416. PubMed DOI PMC
Davis MJ, Swanson JA. Technical advance: Caspase-1 activation and IL-1β release correlate with the degree of lysosome damage, as illustrated by a novel imaging method to quantify phagolysosome damage. J Leukoc Biol. 2010;88(4):813–822. doi: 10.1189/jlb.0310159. PubMed DOI PMC
Orlinska U, Newton RC. Role of glucose in interleukin-1 beta production by lipopolysaccharide-activated human monocytes. J Cell Physiol. 1993;157(1):201–208. doi: 10.1002/jcp.1041570126. PubMed DOI
Cotzomi-Ortega I, et al. Autophagy inhibition induces the secretion of macrophage migration inhibitory factor (MIF) with autocrine and paracrine effects on the promotion of malignancy in breast cancer. Biology. 2020;9(1):20. doi: 10.3390/biology9010020. PubMed DOI PMC
Li M, et al. Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity. J Biol Chem. 2013;288(50):35769–35780. doi: 10.1074/jbc.M113.511212. PubMed DOI PMC
Deng J, et al. The role of autophagy and amphisomes in virus recognition, TLR 9 recruitment and virus-stimulated IFN-α production by human plasmacytoid dendritic cells (pDC) (45.19) J Immunol. 2012;188(1 Supplement):45.19.
Mauvezin C, et al. Autophagosome-lysosome fusion is independent of V-ATPase-mediated acidification. Nat Commun. 2015;6:7007. doi: 10.1038/ncomms8007. PubMed DOI PMC
van Deurs B, Holm PK, Sandvig K. Inhibition of the vacuolar H(+)-ATPase with bafilomycin reduces delivery of internalized molecules from mature multivesicular endosomes to lysosomes in HEp-2 cells. Eur J Cell Biol. 1996;69(4):343–350. PubMed
van Weert AW, et al. Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J Cell Biol. 1995;130(4):821–834. doi: 10.1083/jcb.130.4.821. PubMed DOI PMC
Zou W, et al. Exosome release is regulated by mTORC1. Adv Sci. 2019;6(3):1801313. doi: 10.1002/advs.201801313. PubMed DOI PMC
Palokangas H, et al. Retrograde transport from the pre-Golgi intermediate compartment and the Golgi complex is affected by the vacuolar H+-ATPase inhibitor bafilomycin A1. Mol Biol Cell. 1998;9(12):3561–3578. doi: 10.1091/mbc.9.12.3561. PubMed DOI PMC
Chen Q, et al. Knockdown of Parkinson’s disease-related gene ATP13A2 reduces tumorigenesis via blocking autophagic flux in colon cancer. Cell Biosci. 2020;10(1):144. doi: 10.1186/s13578-020-00506-z. PubMed DOI PMC
Bento CF, et al. The Parkinson’s disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway. Nat Commun. 2016;7(1):11803. doi: 10.1038/ncomms11803. PubMed DOI PMC
Kong SM, et al. Parkinson’s disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes. Hum Mol Genet. 2014;23(11):2816–2833. doi: 10.1093/hmg/ddu099. PubMed DOI
Minakaki G, et al. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2018;14(1):98–119. doi: 10.1080/15548627.2017.1395992. PubMed DOI PMC
Sharma G, et al. A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis. Autophagy. 2019;15(10):1694–1718. doi: 10.1080/15548627.2019.1586257. PubMed DOI PMC
Dong XP, et al. PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome. Nat Commun. 2010;1(4):38. doi: 10.1038/ncomms1037. PubMed DOI PMC
Li SC, et al. The signaling lipid PI(3,5)P2 stabilizes V1-V(o) sector interactions and activates the V-ATPase. Mol Biol Cell. 2014;25(8):1251–1262. doi: 10.1091/mbc.e13-10-0563. PubMed DOI PMC
Hessvik NP, et al. PIKfyve inhibition increases exosome release and induces secretory autophagy. Cell Mol Life Sci. 2016;73(24):4717–4737. doi: 10.1007/s00018-016-2309-8. PubMed DOI PMC
Ji X, Zhang X, Li Z. ULK1 inhibitor induces spindle microtubule disorganization and inhibits phosphorylation of Ser10 of histone H3. FEBS Open Biol. 2020;10(11):2452–2463. doi: 10.1002/2211-5463.13000. PubMed DOI PMC
Karve S, et al. Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery. Proc Natl Acad Sci U S A. 2012;109(21):8230–8235. doi: 10.1073/pnas.1120508109. PubMed DOI PMC
Guo J, et al. Potent USP10/13 antagonist spautin-1 suppresses melanoma growth via ROS-mediated DNA damage and exhibits synergy with cisplatin. J Cell Mol Med. 2020;24(7):4324–4340. doi: 10.1111/jcmm.15093. PubMed DOI PMC
Pellegrini P, et al. Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies. Autophagy. 2014;10(4):562–571. doi: 10.4161/auto.27901. PubMed DOI PMC
Collins KP, Jackson KM, Gustafson DL. Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation. J Pharmacol Exp Ther. 2018;365(3):447–459. doi: 10.1124/jpet.117.245639. PubMed DOI PMC
Bayer N, et al. Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection. J Virol. 1998;72(12):9645–9655. doi: 10.1128/JVI.72.12.9645-9655.1998. PubMed DOI PMC